This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
The U.S. Food and Drug Administration (FDA) has announced that it will conduct targeted sampling of leafy greens as part of the Leafy Greens STEC Action Plan (LGAP). The agency also provided updates on the progress of LGAP and a summary report of a 2021 sampling assignment.
The U.S. Food and Drug Administration provided an update about its ongoing Cyclospora cayetanensis prevention and research efforts under the Cyclospora Prevention, Response and Research Action Plan, including the publication of an article in Food Safety Magazine.